Mead Johnson Nutrition Company MJN
-
Abbott Labs - Split Will Unlock Nutritionals Business
By Peter Maciejewski : Abbott Labs ( ABT ) plans to split into two companies by the end of 2012. There will be the proprietary pharmaceutical business with $17.4 billion in annual revenue and the other businesses of nutritional products, diagnostics established pharmaceuticals, medical devices ...
-
Mead Johnson Nutrition ( MJN ): Q1 EPS of $0.82 beats by $0.04. Revenue of $986M (+9.6% Y/Y) beats by $9M. (PR)
Mead Johnson Nutrition ( MJN ): Q1 EPS of $0.82 beats by $0.04 . Revenue of $986M (+9.6% Y/Y) beats by $9M . ( PR ) Post your comment!
-
Notable earnings before Thursday's open: [[ABC]], [[AET]], [[AMLN]], [[AUO]], [[AZN]], [[BC]], [[BG]], [[BLLL]], [[BMY]], [[BWA]], [[CAM]], [[CCE]], [[CELG]], [[CL]], [[CMS]], [[CNX]], [[D]], [[DB]], ...
… DNKN , DOW , ELN , EQT , ETR , FIS , GR , GTI , HOT , HP , INCY , IPG , IRM , IVZ , JBLU , K , LINE , LIZ , LLL , LMT , MCO , MJN , MO , MWW , MYL , NBL , NIHD , OCR , ORI , OXY , PCS , PDS , PEP , PHM , POT , PTEN , RTN , SHPGY , SWC , SWI , SWY , TLAB …
-
Pfizer Nutritions Sale Signals Buybacks, Enhanced Core Focus
By Benzinga : By Ilir Shkurti Pfizer's ( PFE ) announcement that it has an agreement to sell its Nutrition business to Nestlé ( NSRGY.PK ) for $11.85 billion in cash has given rise to expectations share valuation catalysts through share repurchasing as well as a renewed focus on core operations. ...
-
Nestle Scores in Deal to Acquire Pfizer's Nutrition Business
… reflects the fact that Nestle wanted to keep this valuable asset out of its competitors' hands (namely Danone BN and Mead Johnson MJN ). From Pfizer's perspective, while Pfizer sold the nutrition unit for a slightly higher than expected price, we don't …
-
Danone ([[DANOY.PK]] -2.3%), bidding along with Mead Johnson ([[ MJN ]] +1.8%), reportedly raises its offer for Pfizer's ([[PFE]] +1.2%) infant nutrition business to nearly $11B. Analysts say Danone ...
Danone ( DANOY.PK -2.3% ), bidding along with Mead Johnson ( MJN +1.8% ), reportedly raises its offer for Pfizer's ( PFE +1.2% ) infant nutrition business to nearly $11B. Analysts …
-
Pfizer: A Compelling Buy Candidate In 2012
… units. One possible buyer for the nutrition business is the French company Danone, and another is Mead Johnson Nutrition ( MJN ), which could bid $10 billion. Pfizer's animal health unit could also receive a bid of up to $18 billion from Bayer …
-
Heinz's Emerging Market Growth Strongly Driven By Infant Nutrition
By Peter Maciejewski : People most associate Heinz ( HNZ ) with its iconic ketchup brand. The Company also has an infant nutrition business which generated 11% of revenue for the fiscal-year ended April 2011 (per 10-K for fiscal year 2011). Investors should be aware of this division and consider ...
-
Nestle (NSRGY.PK) and Danone (DANOY.PK) have submitted preliminary bids of ~$10B for Pfizer's (PFE) infant nutrition business, according to Bloomberg, in-line with the unit's estimated value. ...
… estimated value . However, with the bids likely to face regulatory hurdles, Nestle is said to be considering making asset sales as part of any deal, while Danone is reportedly considering a joint bid with Mead Johnson ( MJN ). Post your comment!
-
New Morningstar Analyst Report - Bristol-Myers Squibb Company
… pharmaceutical operations, we estimate a 9.5% cost of equity. Bristol's divestiture of its nutritional business Mead Johnson MJN , through a spin-off in late 2009, reduced the firm's share count by close to 14%, which was largely offset by the lost …